Several factors can affect the efficiency and outcome of Phase I metabolism. Genetic polymorphisms in CYP enzymes can lead to significant interindividual differences in metabolic capacity, impacting an individual's susceptibility to toxic effects. Additionally, environmental factors such as diet, smoking, and exposure to other chemicals can induce or inhibit enzyme activity, altering the metabolism of xenobiotics.
